Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]

Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]

Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773—781. Page 775, left column, third paragraph, line 4, the text “(p<0.5)” should read “(p<0.05)”. Page 775, left column, second line from the bottom, the text &...

Full description

Bibliographic Details
Main Authors: Hisanaga K, Uchino H, Kakisu N, Miyagi M, Yoshikawa F, Sato G, Isobe K, Kishi K, Homma S, Hirose T
Format: Article
Language:English
Published: Dove Medical Press 2021-07-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
immune checkpoint inhibitor
diabetes
overall survival
progression-free survival
Online Access:https://www.dovepress.com/corrigendum-pre-existing-diabetes-limits-survival-rate-after-immune-ch-peer-reviewed-fulltext-article-DMSO

Similar Items

Similar Items